E-viri
PDF
Recenzirano
Odprti dostop
-
Sullivan, Sheena G; Chilver, Monique B; Carville, Kylie S; Deng, Yi-Mo; Grant, Kristina A; Higgins, Geoff; Komadina, Naomi; Leung, Vivian Ky; Minney-Smith, Cara A; Teng, Don; Tran, Thomas; Stocks, Nigel; Fielding, James E
Euro surveillance : bulletin européen sur les maladies transmissibles, 10/2017, Letnik: 22, Številka: 43Journal Article
In 2017, influenza seasonal activity was high in the southern hemisphere. We present interim influenza vaccine effectiveness (VE) estimates from Australia. Adjusted VE was low overall at 33% (95% confidence interval (CI): 17 to 46), 50% (95% CI: 8 to 74) for A(H1)pdm09, 10% (95% CI: -16 to 31) for A(H3) and 57% (95% CI: 41 to 69) for influenza B. For A(H3), VE was poorer for those vaccinated in the current and prior seasons.
